LAPOINTE ANTHONY GREGG 4
4 · RIGEL PHARMACEUTICALS INC · Filed May 29, 2024
Insider Transaction Report
Form 4
LAPOINTE ANTHONY GREGG
Director
Transactions
- Award
Common Stock
2024-05-25+25,000→ 100,000 total - Award
Stock Option (Right to Buy)
2024-05-25+30,000→ 30,000 totalExercise: $0.91Exp: 2034-05-25→ Common Stock (30,000 underlying)
Footnotes (2)
- [F1]The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on the date prior to the Company's next Annual Meeting, subject to the Reporting Person's continuous service on the Company's Board of Directors.
- [F2]The shares vest monthly over one (1) year from the date of grant, subject to the Reporting Person's continuous service on the Company's Board of Directors.